Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02784
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CNS Lymphoma Mimicking a Demyelinating Lesion

Journal of Evolution of Medical and Dental Sciences
2015English

A Polysaccharide From the Human Commensal Bacteroides Fragilis Protects Against CNS Demyelinating Disease

Mucosal Immunology
AllergyImmunology
2010English

Cerebrospinal Fluid Analysis in the Context of CNS Demyelinating Diseases

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2013English

Early Antiretroviral Therapy Improves Neurodevelopmental Outcomes in Infants

AIDS
Infectious DiseasesAllergyImmunology
2012English

Gene Therapy for CNS Diseases – Krabbe Disease

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2016English

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders

English

Decreased Serum Tuftsin Concentrations in Sickle Cell Disease.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1980English

Cell Therapy in Demyelinating Diseases

NeuroRX
2004English

Switching Therapy to Fingolimod Improves Clinical and Mri Outcomes

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy